SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001255294-14-001194
Filing Date
2014-11-19
Accepted
2014-11-19 14:51:44
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q/A 336299
2 EXHIBIT 10.23 ex10_23.htm EX-10.23 113568
3 EX31_1 ex31_1.htm EX-31.1 9087
4 EX31_2 ex31_2.htm EX-31.2 9156
5 EX32_1 ex32_1.htm EX-32.1 4070
  Complete submission text file 0001255294-14-001194.txt   3602741

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rcha-20140930.xml EX-101.INS 423127
7 XBRL SCHEMA FILE rcha-20140930.xsd EX-101.SCH 42824
8 XBRL CALCULATION FILE rcha-20140930_cal.xml EX-101.CAL 35961
9 XBRL DEFINITION FILE rcha-20140930_def.xml EX-101.DEF 111855
10 XBRL LABEL FILE rcha-20140930_lab.xml EX-101.LAB 204480
11 XBRL PRESENTATION FILE rcha-20140930_pre.xml EX-101.PRE 198392
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 000-54767 | Film No.: 141234747
SIC: 2834 Pharmaceutical Preparations